Cargando…
Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
ATM and ATR protein kinases play a crucial role in cellular DNA damage responses. The inhibition of ATM and ATR can lead to the abolition of the function of cell cycle checkpoints. In this regard, it is expected that checkpoint inhibitors can serve as sensitizing agents for anti-cancer chemo/radioth...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761266/ https://www.ncbi.nlm.nih.gov/pubmed/19625493 http://dx.doi.org/10.1093/nar/gkp593 |
_version_ | 1782172817395023872 |
---|---|
author | Nishida, Hiroshi Tatewaki, Naoto Nakajima, Yuki Magara, Taku Ko, Kam Ming Hamamori, Yasuo Konishi, Tetsuya |
author_facet | Nishida, Hiroshi Tatewaki, Naoto Nakajima, Yuki Magara, Taku Ko, Kam Ming Hamamori, Yasuo Konishi, Tetsuya |
author_sort | Nishida, Hiroshi |
collection | PubMed |
description | ATM and ATR protein kinases play a crucial role in cellular DNA damage responses. The inhibition of ATM and ATR can lead to the abolition of the function of cell cycle checkpoints. In this regard, it is expected that checkpoint inhibitors can serve as sensitizing agents for anti-cancer chemo/radiotherapy. Although several ATM inhibitors have been reported, there are no ATR-specific inhibitors currently available. Here, we report the inhibitory effect of schisandrin B (SchB), an active ingredient of Fructus schisandrae, on ATR activity in DNA damage response. SchB treatment significantly decreased the viability of A549 adenocarcinoma cells after UV exposure. Importantly, SchB treatment inhibited both the phosphorylation levels of ATM and ATR substrates, as well as the activity of the G2/M checkpoint in UV-exposed cells. The protein kinase activity of immunoaffinity-purified ATR was dose-dependently decreased by SchB in vitro (IC(50): 7.25 μM), but the inhibitory effect was not observed in ATM, Chk1, PI3K, DNA-PK, and mTOR. The extent of UV-induced phosphorylation of p53 and Chk1 was markedly reduced by SchB in ATM-deficient but not siATR-treated cells. Taken together, our demonstration of the ability of SchB to inhibit ATR protein kinase activity following DNA damage in cells has clinical implications in anti-cancer therapy. |
format | Text |
id | pubmed-2761266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27612662009-10-14 Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response Nishida, Hiroshi Tatewaki, Naoto Nakajima, Yuki Magara, Taku Ko, Kam Ming Hamamori, Yasuo Konishi, Tetsuya Nucleic Acids Res Genome Integrity, Repair and Replication ATM and ATR protein kinases play a crucial role in cellular DNA damage responses. The inhibition of ATM and ATR can lead to the abolition of the function of cell cycle checkpoints. In this regard, it is expected that checkpoint inhibitors can serve as sensitizing agents for anti-cancer chemo/radiotherapy. Although several ATM inhibitors have been reported, there are no ATR-specific inhibitors currently available. Here, we report the inhibitory effect of schisandrin B (SchB), an active ingredient of Fructus schisandrae, on ATR activity in DNA damage response. SchB treatment significantly decreased the viability of A549 adenocarcinoma cells after UV exposure. Importantly, SchB treatment inhibited both the phosphorylation levels of ATM and ATR substrates, as well as the activity of the G2/M checkpoint in UV-exposed cells. The protein kinase activity of immunoaffinity-purified ATR was dose-dependently decreased by SchB in vitro (IC(50): 7.25 μM), but the inhibitory effect was not observed in ATM, Chk1, PI3K, DNA-PK, and mTOR. The extent of UV-induced phosphorylation of p53 and Chk1 was markedly reduced by SchB in ATM-deficient but not siATR-treated cells. Taken together, our demonstration of the ability of SchB to inhibit ATR protein kinase activity following DNA damage in cells has clinical implications in anti-cancer therapy. Oxford University Press 2009-09 2009-07-22 /pmc/articles/PMC2761266/ /pubmed/19625493 http://dx.doi.org/10.1093/nar/gkp593 Text en © 2009 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Genome Integrity, Repair and Replication Nishida, Hiroshi Tatewaki, Naoto Nakajima, Yuki Magara, Taku Ko, Kam Ming Hamamori, Yasuo Konishi, Tetsuya Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response |
title | Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response |
title_full | Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response |
title_fullStr | Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response |
title_full_unstemmed | Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response |
title_short | Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response |
title_sort | inhibition of atr protein kinase activity by schisandrin b in dna damage response |
topic | Genome Integrity, Repair and Replication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761266/ https://www.ncbi.nlm.nih.gov/pubmed/19625493 http://dx.doi.org/10.1093/nar/gkp593 |
work_keys_str_mv | AT nishidahiroshi inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse AT tatewakinaoto inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse AT nakajimayuki inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse AT magarataku inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse AT kokamming inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse AT hamamoriyasuo inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse AT konishitetsuya inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse |